Pfizer asks US regulators to authorize experimental COVID-19 pill

pfizer asks us regulators to authorize experimental covid 19 pill

Sumary of Pfizer asks US regulators to authorize experimental COVID-19 pill:

  • Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
  • MARYLAND PARENTS NOTIFIED CHILDREN WERE GIVEN WRONG DOSAGE OF PFIZER VACCINE AT SCHOOL CLINIC This image provided by Pfizer shows its COVID-19 pill.
  • Specifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill.
  • But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.
  • The FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision.
  • The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.
  • Some experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.
  • Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close